Log in

NASDAQ:HARPHarpoon Therapeutics News Headlines

$11.87
+0.76 (+6.84 %)
(As of 04/7/2020 06:16 AM ET)
Add
Compare
Today's Range
$11.28
Now: $11.87
$12.14
50-Day Range
$10.74
MA: $13.40
$16.32
52-Week Range
$9.77
Now: $11.87
$21.47
Volume73,200 shs
Average Volume80,174 shs
Market Capitalization$296.04 million
P/E RatioN/A
Dividend YieldN/A
Beta0.92

Headlines

Harpoon Therapeutics (NASDAQ HARP) News Headlines

Source:
DateHeadline
Harpoon Therapeutics Inc (NASDAQ:HARP) Sees Large Increase in Short InterestHarpoon Therapeutics Inc (NASDAQ:HARP) Sees Large Increase in Short Interest
www.americanbankingnews.com - April 1 at 4:54 PM
Companies Like Harpoon Therapeutics (NASDAQ:HARP) Can Afford To Invest In GrowthCompanies Like Harpoon Therapeutics (NASDAQ:HARP) Can Afford To Invest In Growth
finance.yahoo.com - March 26 at 1:47 PM
Harpoon Therapeutics Inc (NASDAQ:HARP) Receives Average Rating of "Buy" from AnalystsHarpoon Therapeutics Inc (NASDAQ:HARP) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - March 19 at 10:17 AM
Wedbush Comments on Harpoon Therapeutics Incs Q1 2020 Earnings (NASDAQ:HARP)Wedbush Comments on Harpoon Therapeutics Inc's Q1 2020 Earnings (NASDAQ:HARP)
www.americanbankingnews.com - March 19 at 9:07 AM
Harpoon Therapeutics (NASDAQ:HARP) Posts  Earnings Results, Misses Estimates By $0.05 EPSHarpoon Therapeutics (NASDAQ:HARP) Posts Earnings Results, Misses Estimates By $0.05 EPS
www.americanbankingnews.com - March 13 at 9:58 PM
Harpoon Therapeutics, Inc. 2019 Q4 - Results - Earnings Call PresentationHarpoon Therapeutics, Inc. 2019 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 13 at 3:51 PM
HC Wainwright Reaffirms "Buy" Rating for Harpoon Therapeutics (NASDAQ:HARP)HC Wainwright Reaffirms "Buy" Rating for Harpoon Therapeutics (NASDAQ:HARP)
www.americanbankingnews.com - March 13 at 9:24 AM
Harpoon Therapeutics EPS misses by $0.06, misses on revenueHarpoon Therapeutics EPS misses by $0.06, misses on revenue
seekingalpha.com - March 12 at 7:43 PM
BRIEF-Harpoon Therapeutics Reports Q4 Revenue Of $2.2 MlnBRIEF-Harpoon Therapeutics Reports Q4 Revenue Of $2.2 Mln
www.reuters.com - March 12 at 7:43 PM
Harpoon Therapeutics, Inc. to Host Earnings CallHarpoon Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - March 12 at 2:42 PM
Harpoon Therapeutics to Report Fourth Quarter 2019 Financial Results and Provide Corporate UpdateHarpoon Therapeutics to Report Fourth Quarter 2019 Financial Results and Provide Corporate Update
finance.yahoo.com - March 5 at 10:11 AM
Harpoon Therapeutics, Inc. Common Stock (HARP) Advanced ChartingHarpoon Therapeutics, Inc. Common Stock (HARP) Advanced Charting
www.nasdaq.com - February 16 at 5:21 PM
Insider Weekends: Darren Jackson Purchases 18,000 Shares Of FastenalInsider Weekends: Darren Jackson Purchases 18,000 Shares Of Fastenal
seekingalpha.com - January 27 at 8:57 AM
Top Insider Buys Highlight for the Week of Jan. 24Top Insider Buys Highlight for the Week of Jan. 24
finance.yahoo.com - January 25 at 8:44 PM
Trade Alert: The Chief Financial Officer Of Harpoon Therapeutics, Inc. (NASDAQ:HARP), Georgia Erbez, Has Just Spent US$94k Buying SharesTrade Alert: The Chief Financial Officer Of Harpoon Therapeutics, Inc. (NASDAQ:HARP), Georgia Erbez, Has Just Spent US$94k Buying Shares
finance.yahoo.com - January 25 at 10:20 AM
BRIEF-Harpoon Says Company And Werewolf Therapeutics Entered Into Second Amended And License AgreementBRIEF-Harpoon Says Company And Werewolf Therapeutics Entered Into Second Amended And License Agreement
www.msn.com - December 27 at 8:02 AM
Hedge Funds Have Never Been This Bullish On Harpoon Therapeutics, Inc. (HARP)Hedge Funds Have Never Been This Bullish On Harpoon Therapeutics, Inc. (HARP)
finance.yahoo.com - December 20 at 12:10 AM
Harpoon Therapeutics (HARP) Presents At Piper Jaffray31st Annual Healthcare Conference - SlideshowHarpoon Therapeutics (HARP) Presents At Piper Jaffray31st Annual Healthcare Conference - Slideshow
seekingalpha.com - December 9 at 5:00 PM
Harpoon Therapeutics, Inc. (HARP) Shares March Higher, Can It Continue?Harpoon Therapeutics, Inc. (HARP) Shares March Higher, Can It Continue?
finance.yahoo.com - December 4 at 12:41 PM
Harpoon Therapeutics to Participate in the Piper Jaffray Healthcare ConferenceHarpoon Therapeutics to Participate in the Piper Jaffray Healthcare Conference
finance.yahoo.com - November 26 at 8:16 AM
Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting TriTAC®, and Expand Existing Discovery CollaborationHarpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting TriTAC®, and Expand Existing Discovery Collaboration
finance.yahoo.com - November 21 at 8:20 AM
Harpoon Therapeutics, Inc. (HARP): Hedge Funds In Wait-and-See ModeHarpoon Therapeutics, Inc. (HARP): Hedge Funds In Wait-and-See Mode
finance.yahoo.com - November 12 at 12:59 PM
Harpoon Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateHarpoon Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - November 6 at 8:38 PM
Harpoon Therapeutics Presents Preclinical Data for HPN328, a DLL3-targeting T Cell Engager, at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsHarpoon Therapeutics Presents Preclinical Data for HPN328, a DLL3-targeting T Cell Engager, at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
finance.yahoo.com - October 29 at 2:24 PM
Harpoon Therapeutics Announces Presentation on HPN328 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsHarpoon Therapeutics Announces Presentation on HPN328 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
finance.yahoo.com - October 22 at 6:45 PM
Will Harpoon Therapeutics, Inc. (NASDAQ:HARP) Need To Raise More Money?Will Harpoon Therapeutics, Inc. (NASDAQ:HARP) Need To Raise More Money?
finance.yahoo.com - September 19 at 3:47 PM
Harpoon Therapeutics EPS beats by $0.16, misses on revenueHarpoon Therapeutics EPS beats by $0.16, misses on revenue
seekingalpha.com - August 5 at 8:35 PM
Harpoon Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateHarpoon Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 5 at 8:35 PM
Harpoon Therapeutics to Participate in Two Upcoming Investor ConferencesHarpoon Therapeutics to Participate in Two Upcoming Investor Conferences
finance.yahoo.com - July 31 at 6:47 PM
How Many Harpoon Therapeutics, Inc. (NASDAQ:HARP) Shares Do Institutions Own?How Many Harpoon Therapeutics, Inc. (NASDAQ:HARP) Shares Do Institutions Own?
finance.yahoo.com - May 26 at 3:22 PM
Harpoon Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate UpdateHarpoon Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - May 9 at 3:28 PM
Health Care Digest: Attacking a deadly infant virus, Medicaid's smoking gun and exporting genetic expertiseHealth Care Digest: Attacking a deadly infant virus, Medicaid's smoking gun and exporting genetic expertise
finance.yahoo.com - April 22 at 7:31 AM
Harpoon doses first patient in mid-stage cancer trialHarpoon doses first patient in mid-stage cancer trial
seekingalpha.com - April 18 at 3:26 PM
Harpoon Therapeutics Doses First Patient with a Mesothelin-Targeting T cell Engager (HPN536) in Phase 1/2a Clinical Trial for Ovarian and Other Solid Tumor CancersHarpoon Therapeutics Doses First Patient with a Mesothelin-Targeting T cell Engager (HPN536) in Phase 1/2a Clinical Trial for Ovarian and Other Solid Tumor Cancers
finance.yahoo.com - April 18 at 3:26 PM
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate UpdateHarpoon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - March 15 at 6:11 AM
HARP Earnings DateHARP Earnings Date
www.nasdaq.com - March 14 at 3:20 PM
Harpoon Therapeutics to Participate in Upcoming William Blair Cancer Immunotherapy ConferenceHarpoon Therapeutics to Participate in Upcoming William Blair Cancer Immunotherapy Conference
finance.yahoo.com - March 14 at 6:22 AM
Shockwave Medical soars 79% after upsized IPO scores $97MShockwave Medical soars 79% after upsized IPO scores $97M
finance.yahoo.com - March 8 at 6:12 AM
Harpoon Therapeutics to Report Fourth Quarter and Full Year 2018 Financial ResultsHarpoon Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - March 8 at 6:12 AM
Shockwave Medical soars after upsized IPO scores $97MShockwave Medical soars after upsized IPO scores $97M
finance.yahoo.com - March 7 at 3:18 PM
Harpoon Therapeutics Platform To Drive Significant Value, Wedbush Says In Bullish InitiationHarpoon Therapeutics' Platform To Drive Significant Value, Wedbush Says In Bullish Initiation
finance.yahoo.com - March 5 at 3:18 PM
Harpoon Therapeutics Inc.Harpoon Therapeutics Inc.
www.barrons.com - March 4 at 3:16 PM
Santa Clara life science company hopes to raise up to $92M after setting IPO targetsSanta Clara life science company hopes to raise up to $92M after setting IPO targets
finance.yahoo.com - February 26 at 5:28 AM
Zoom Video may be ready for its IPO in AprilZoom Video may be ready for its IPO in April
finance.yahoo.com - February 25 at 12:03 PM
Harpoon Therapeutics to Present at SVB Leerink Global Healthcare ConferenceHarpoon Therapeutics to Present at SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 20 at 3:16 PM
Arix Bioscience plc: Harpoon Closes Initial Public OfferingArix Bioscience plc: Harpoon Closes Initial Public Offering
finance.yahoo.com - February 14 at 10:43 AM
This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel